Sustainable Packaging Market to be Worth USD 400 Million By 2024 – Zion Market Research
/
Date24 Nov 2018
Email Print Friendly Share New York, NY, Nov. 23, 2018 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Sustainable Packaging Market... Read More →
Pekka Ojanpää, upcoming President & CEO of Suominen, dies in aviation accident
/
Date24 Nov 2018
Email Print Friendly Share Suominen Corporation Stock Exchange Release 24 November 2018 at 20.35 pm EET Pekka Ojanpää, upcoming President & CEO of Suominen, dies... Read More →
Timbercreek Financial Declares November 2018 Dividend
/
Date24 Nov 2018
Email Print Friendly Share TORONTO, Nov. 23, 2018 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that its board of... Read More →
AS VALMIERAS STIKLA ŠĶIEDRA neauditēta konsolidēta finanšu informācija par 2018.gada 9 mēnešiem
/
Date24 Nov 2018
Email Print Friendly Share AS VALMIERAS STIKLA ŠĶIEDRA valde dažādu uzņēmuma aktualitāšu dēļ nolēmusi publicēt 2018.gada 9 mēnešu rezultātus pirms plānotā termiņa. Pēdējos mēnešos uzņēmums... Read More →
North American Construction Group Closes Acquisition of Heavy Construction Fleet
/
Date24 Nov 2018
Email Print Friendly Share ACHESON, Alberta, Nov. 23, 2018 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA.TO/NYSE:NOA) today announced the... Read More →
MINISTRY OF COMMUNITY DEVELOPMENT – MOCD, UAE ADOPTS PROOF OF CONCEPT BY PROXIMAX
/
Date24 Nov 2018
Email Print Friendly Share GIBRALTAR, Nov. 13, 2018 (GLOBE NEWSWIRE) — (via Blockchain Wire) The Ministry of Community Development of the United Arab Emirates announced... Read More →
IIDA Launches First-of-its-Kind Indicator of Industry’s Economic Health
/
Date24 Nov 2018
Email Print Friendly Share Chicago, Nov. 14, 2018 (GLOBE NEWSWIRE) — IIDA announces its inaugural IIDA Index, an analysis of economic health for the commercial design... Read More →
European Commission Approves Spark Therapeutics’ LUXTURNA® (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations
/
Date24 Nov 2018
Email Print Friendly Share LUXTURNA is first gene therapy for a genetic disease approved in both the U.S. and EU LUXTURNA is first and only... Read More →